Home
R&D
Research and development status
R&D
| Class | Project | Description | Development stage |
|---|---|---|---|
| NCE (New Chemical Entity) |
SA09012 | LTRA for Asthma | Phase II (completed) |
| IMD (Incrementally Modified Drugs) |
Viasin® gran. | the world’s 1st granule formulation of Sildenafil |
Launched |
| Citus™ dry syr. | the world’s 1st new indication (Allergic rhinitis for pediatrics) |
Launched | |
| Citus™ dispersible tab. Dispersible tab. |
New formulation | Launched | |
| Citus™ tab. | New dosage | Launched | |
| Hebron-F® tab. | New formulation | Launched | |
| Camodix® dispersible tab. | New formulation | Launched | |
| Roxigran® gran. | New formulation | Launched | |
| SAMA Domperidone gran. | New formulation | Launched | |
| Setopen™ dry syr. | New formulation | Launched |